The HDA Research Foundation’s Board of Directors is composed of healthcare’s most respected leaders, who serve as experts advancing the Foundation’s mission and ensuring its financial stability.
The 2016 Foundation’s Board of Directors includes 13 members. Terms of office are three years, and members may serve up to two consecutive terms.
Chairman of the Board
Vice President, Access & Channel Management
Genentech Inc., A Member of the Roche Group
Vice Chairman of the Board
Value Drug Company
Director, National Accounts, Trade & Specialty Distribution
Boehringer Ingelheim Pharmaceuticals, Inc.
VP and Head, Trade Operations and Analytics
Novartis Pharmaceuticals Corporation
Executive Vice President, Global Sourcing
Cardinal Health, Inc.
Executive Vice President, Industry Relations, Membership & Education and COO, HDA Research Foundation
Healthcare Distribution Alliance
Senior Vice President, General Manager, US & LATAM
Senior Vice President, U.S. Specialty Medicines Trade Relations
Teva Pharmaceuticals USA
President, Global Sourcing & Manufacturer Relations
Executive Director - Market Access
SVP & President
Senior Vice President, North America National Accounts and Channel Development
Senior Vice President, Manufacturer Services
McKesson Specialty Health
John M. Gray, Ex Officio
President, HDA Research Foundation
President & CEO, HDA
Secretary/Treasurer, HDA Research Foundation
Executive Vice President & COO, HDA
Arthur Y. Tsien, Esq.
Olsson, Frank and Weeda, P.C.